Researchers at The University of Texas MD Anderson Cancer Center are sending T-cells to the International Space Station to investigate how microgravity affects the cells, which could lead to advancements in treatments for cancer and autoimmune diseases.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
